Previous research of our group has shown that addressing the varied levels of relevant cytokines of the disease, including IL-13, IL-31 and IL-9, produced by CLA+ memory T cells in an ex vivo model of AD, is essential for stratifying patients based on clinical features like disease severity and pruritus (19–21). This evidence concerns the gene SELPLG and Alzheimer disease.